CG Oncology Announces Presentation of the First Phase 3 Monotherapy Data for Cretostimogene Grenadenorepvec in BCG-Unresponsive NMIBC Patients at SUO 2023 by Seini Moimoi | Nov 14, 2023 | Portfolio News
Endeavor BioMedicines Enters License Agreement With Hummingbird Bioscience For Worldwide Rights To HMBD-501, A Next Generation HER3-Targeted Antibody-Drug Conjugate (ADC) by Seini Moimoi | Oct 19, 2023 | Portfolio News
Mirum Pharmaceuticals Announces New PDUFA Date for LIVMARLI for the Treatment of Cholestatic Pruritus in Progressive Familial Intrahepatic Cholestasis by Seini Moimoi | Oct 17, 2023 | Portfolio News
Quanta Therapeutics Presents Late-Breaking Data for QTX3034, a multi-KRAS inhibitor, at AACR-NCI-EORTC Conference by Seini Moimoi | Oct 11, 2023 | Portfolio News
CuraSen Therapeutics Announces Strategic Investment from the Alzheimer’s Drug Discovery Foundation to Advance CST-3056, an Alpha-1A Adrenoceptor Agonist, for the Treatment of Alzheimer’s Disease by Seini Moimoi | Oct 9, 2023 | Portfolio News
Mirum Pharmaceuticals Announces Positive Phase 3 RESTORE Study Results Evaluating Chenodal in Patients with Cerebrotendinous Xanthomatosis by Seini Moimoi | Oct 2, 2023 | Portfolio News
